Apollo Group seeks CCI approval to reorganize its digital and pharmacy businesses under a new entity aimed at eventual market listing.
Apollo Group has initiated a restructuring proposal that brings its pharmacy and digital health operations under a single roof ahead of a planned market listing. According to The Economic Times, the group has filed for approval with the Competition Commission of India (CCI) for a composite scheme that includes the demerger of Apollo Hospitals Enterprise’s pharmacy distribution, digital health platform Apollo 24|7, and telehealth services into a new company called Apollo Healthtech (AHTL).
The next step in the plan involves merging Keimed, the wholesale pharmacy arm, into AHTL. This would create a single entity with an estimated revenue of ₹16,300 crore in FY25, combining both retail and digital healthcare delivery services. The group has stated that the new company will be listed in the next 18 to 21 months.
In addition, as part of the proposal, the new entity will acquire a 74.5 per cent stake in Apollo Medicals (AMPL) through a share purchase agreement already in place. The move is intended to streamline ownership and operations across the healthcare supply chain.
In a related development, Manipal Health Enterprises has also approached CCI for approval to acquire full ownership of Sahyadri Hospitals in multiple phases, as per a separate filing. These filings reflect a broader trend of consolidation and digital integration in India’s private healthcare sector as hospital networks pursue scale and service expansion.
